☰

Sofia D. Merajver - Publications

Affiliations: 
University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Epidemiology, Public Health, Molecular Biology
Tree Info Similar researchers PubMed Report error

268 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Laws A, Leonard S, Hershey E, Stokes S, Vincuilla J, Sharma E, Milliron K, Garber JE, Merajver SD, King TA, Pilewskie ML. ASO Visual Abstract: Upgrade Rates and Breast Cancer Development Among Germline Pathogenic Variant Carriers with High-Risk Breast Lesions. Annals of Surgical Oncology. PMID 38366181 DOI: 10.1245/s10434-024-15067-5  0.384
2024 Laws A, Leonard S, Hershey E, Stokes S, Vincuilla J, Sharma E, Milliron K, Garber JE, Merajver SD, King TA, Pilewskie ML. Upgrade Rates and Breast Cancer Development Among Germline Pathogenic Variant Carriers with High-Risk Breast Lesions. Annals of Surgical Oncology. PMID 38261128 DOI: 10.1245/s10434-024-14947-0  0.424
2023 Liu Y, Joy ST, Henley MJ, Croskey A, Yates JA, Merajver SD, Mapp AK. Inhibition of CREB Binding and Function with a Dual-Targeting Ligand. Biochemistry. PMID 38086054 DOI: 10.1021/acs.biochem.3c00469  0.371
2023 Daly MB, Pal T, Maxwell KN, Churpek J, Kohlmann W, AlHilli Z, Arun B, Buys SS, Cheng H, Domchek SM, Friedman S, Giri V, Goggins M, Hagemann A, Hendrix A, ... ... Merajver SD, et al. NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024. Journal of the National Comprehensive Cancer Network : Jnccn. 21: 1000-1010. PMID 37856201 DOI: 10.6004/jnccn.2023.0051  0.408
2022 Fleege NMG, Pierce-Gjeldum D, Swartz LK, Verbal K, Merajver S, Friese CR, Kiyota A, Heth J, Leung D, Smith SR, Gabel N, Kim MM, Morikawa A. IMPACT the Brain: A Team-Based Approach to Management of Metastatic Breast Cancer With CNS Metastases. Jco Oncology Practice. OP2200291. PMID 36223556 DOI: 10.1200/OP.22.00291  0.305
2021 Abraham HG, Ulintz PJ, Goo L, Yates JA, Little AC, Bao L, Wu Z, Merajver SD. RhoC Modulates Cell Junctions and Type I Interferon Response in Aggressive Breast Cancers. Frontiers in Oncology. 11: 712041. PMID 34513691 DOI: 10.3389/fonc.2021.712041  0.426
2021 Lloyd JP, Soellner MB, Merajver SD, Li JZ. Impact of between-tissue differences on pan-cancer predictions of drug sensitivity. Plos Computational Biology. 17: e1008720. PMID 33630864 DOI: 10.1371/journal.pcbi.1008720  0.332
2021 Jiagge EM, Ulintz PJ, Wong S, McDermott SP, Fossi SI, Suhan TK, Hoenerhoff MJ, Bensenhaver JM, Salem B, Dziubinski M, Oppong JK, Aitpillah F, Ishmael K, Osei-Bonsu E, Adjei E, ... ... Merajver SD, et al. Multiethnic PDX models predict a possible immune signature associated with TNBC of African ancestry. Breast Cancer Research and Treatment. PMID 33576900 DOI: 10.1007/s10549-021-06097-8  0.48
2021 Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Goggins M, Hutton ML, Karlan BY, Khan S, Klein C, Kohlmann W, ... ... Merajver SD, et al. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : Jnccn. 19: 77-102. PMID 33406487 DOI: 10.6004/jnccn.2021.0001  0.436
2020 Bhatia S, Palomares MR, Hageman L, Chen Y, Landier W, Adams K, Umphrey H, Reich CA, Zamora KW, Armenian SH, Bevers TB, Blaes AH, Henderson TO, Hodgson DC, Hudson MM, ... ... Merajver SD, et al. A Randomized Phase IIb Study of Low-dose Tamoxifen in Chest-irradiated Cancer Survivors at risk for Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33272980 DOI: 10.1158/1078-0432.CCR-20-3609  0.433
2020 Abraham HG, Xia Y, Mukherjee B, Merajver SD. Incidence and survival of inflammatory breast cancer between 1973 and 2015 in the SEER database. Breast Cancer Research and Treatment. PMID 33033965 DOI: 10.1007/s10549-020-05938-2  0.434
2020 Katapodi MC, Ming C, Northouse LL, Duffy SA, Duquette D, Mendelsohn-Victor KE, Milliron KJ, Merajver SD, Dinov ID, Janz NK. Genetic Testing and Surveillance of Young Breast Cancer Survivors and Blood Relatives: A Cluster Randomized Trial. Cancers. 12. PMID 32899538 DOI: 10.3390/Cancers12092526  0.439
2020 Schairer C, Hablas A, Eldein IAS, Gaafar R, Rais H, Mezlini A, Ayed FB, Ayoub WB, Benider A, Tahri A, Khouchani M, Aboulazm D, Karkouri M, Eissa S, Bastawisy AE, ... ... Merajver SD, et al. Risk factors for inflammatory and non-inflammatory breast cancer in North Africa. Breast Cancer Research and Treatment. PMID 32876910 DOI: 10.1007/S10549-020-05864-3  0.508
2020 Oliver CR, Westerhof TM, Castro MG, Merajver SD. Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography. Journal of Visualized Experiments : Jove. PMID 32865534 DOI: 10.3791/61654  0.377
2020 Liao Y, Gose JW, Arruda EM, Liu AP, Merajver SD, Young YL. Shock wave impact on the viability of MDA-MB-231 cells. Plos One. 15: e0234138. PMID 32497154 DOI: 10.1371/Journal.Pone.0234138  0.301
2020 Daly MB, Pilarski R, Yurgelun MB, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Garber JE, Goggins M, Hutton ML, Khan S, Klein C, Kohlmann W, ... ... Merajver SD, et al. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020. Journal of the National Comprehensive Cancer Network : Jnccn. 18: 380-391. PMID 32259785 DOI: 10.6004/Jnccn.2020.0017  0.466
2020 Aw Yong KM, Ulintz PJ, Caceres S, Cheng X, Bao L, Wu Z, Jiagge EM, Merajver SD. Heterogeneity at the invasion front of triple negative breast cancer cells. Scientific Reports. 10: 5781. PMID 32238832 DOI: 10.1038/S41598-020-62516-8  0.515
2020 Gilani RA, Phadke S, Bao LW, Lachacz EJ, Dziubinski ML, Brandvold KR, Steffey ME, Kwarcinski FE, Graveel CR, Kidwell KM, Merajver SD, Soellner MB. Retraction: UM-164: A Potent c-Src/p38 Kinase Inhibitor with Activity against Triple-Negative Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 26: 1777. PMID 32238414 DOI: 10.1158/1078-0432.CCR-20-0653  0.37
2020 Chandler BC, Moubadder L, Ritter CL, Liu M, Cameron M, Wilder-Romans K, Zhang A, Pesch AM, Michmerhuizen AR, Hirsh N, Androsiglio M, Ward T, Olsen E, Niknafs YS, Merajver S, et al. TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination. The Journal of Clinical Investigation. PMID 31961339 DOI: 10.1172/Jci130435  0.446
2020 Cook AM, Keren DF, McCain L, Schroeder LF, Milliron K, Merajver S, Harper D, Zazove P, Farrehi J, Ernst S, Parvaz J. BPI20-008: Pilot Testing of InheRET™, an Online Tool to Facilitate NCCN Guideline®-Compliant Referrals for Cancer Genetic Counseling and Increase Access to Care Journal of the National Comprehensive Cancer Network. 18. DOI: 10.6004/Jnccn.2019.7480  0.344
2020 Milliron KJ, Cook A, Keren D, McCain LA, Schroeder L, Hulswit B, Arthurs J, Harper DM, Ernst S, Zazove P, Parvaz J, Merajver S. Test of an online tool to facilitate NCCN guideline-compliant access to cancer genetics care. Journal of Clinical Oncology. 38: 1542-1542. DOI: 10.1200/Jco.2020.38.15_Suppl.1542  0.365
2020 Chandler B, Moubadder L, Ritter C, Liu M, Cameron M, Wilder-Romans K, Zhang A, Pesch A, Michmerhuizen A, Hirsh N, Androsiglio M, Ward T, Olsen E, Niknafs Y, Merajver S, et al. Abstract 6273: TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination Cancer Research. 80: 6273-6273. DOI: 10.1158/1538-7445.Am2020-6273  0.509
2020 Vince R, Quarles J, Jacobs M, Luke M, Kaffenberger S, Salami S, Das S, Solorzano M, Stoffel E, Merajver S, Hafron J, Morgan T. Pd48-06 Detection Of Germline Mutations In Localized And Metastatic Prostate Cancer Through Guidline-Based Testing The Journal of Urology. 203. DOI: 10.1097/Ju.0000000000000942.06  0.31
2020 Marchetti* KA, Merrill N, Vandecan N, Bao L, Cheng X, Udager A, Herrel LA, Montgomery J, Hafez K, Morgan T, Weizer A, Alva A, Soellner M, Merajver S, Kaffenberger S. PD47-11 RAPID ORGANOID DEVELOPMENT, DRUG SCREENING, AND NEOADJUVANT CHEMOTHERAPY RESPONSE PREDICTION FOR PATIENTS WITH LOCALLY-ADVANCED BLADDER CANCER The Journal of Urology. 203: e929. DOI: 10.1097/Ju.0000000000000934.011  0.321
2019 Merrill NM, Lachacz EJ, Vandecan NM, Ulintz PJ, Bao L, Lloyd JP, Yates JA, Morikawa A, Merajver SD, Soellner MB. Molecular determinants of drug response in TNBC cell lines. Breast Cancer Research and Treatment. PMID 31655920 DOI: 10.1007/S10549-019-05473-9  0.412
2019 Altemus MA, Goo LE, Little AC, Yates JA, Cheriyan HG, Wu ZF, Merajver SD. Breast cancers utilize hypoxic glycogen stores via PYGB, the brain isoform of glycogen phosphorylase, to promote metastatic phenotypes. Plos One. 14: e0220973. PMID 31536495 DOI: 10.1371/Journal.Pone.0220973  0.571
2019 Newman LA, Jenkins B, Chen Y, Oppong JK, Adjei E, Jibril AS, Hoda S, Cheng E, Chitale D, Bensenhaver JM, Awuah B, Bekele M, Abebe E, Kyei I, Aitpillah F, ... ... Merajver S, et al. Hereditary Susceptibility for Triple Negative Breast Cancer Associated With Western Sub-Saharan African Ancestry: Results From an International Surgical Breast Cancer Collaborative. Annals of Surgery. PMID 31356281 DOI: 10.1097/Sla.0000000000003459  0.554
2019 Little AC, Pathanjeli P, Wu Z, Bao L, Goo LE, Yates JA, Oliver CR, Soellner MB, Merajver SD. IL-4/IL-13 Stimulated Macrophages Enhance Breast Cancer Invasion Via Rho-GTPase Regulation of Synergistic VEGF/CCL-18 Signaling. Frontiers in Oncology. 9: 456. PMID 31214501 DOI: 10.3389/Fonc.2019.00456  0.516
2019 Schairer C, Hablas A, Eldein IAS, Gaafar R, Rais H, Mezlini A, Ayed FB, Ayoub WB, Benider A, Tahri A, Khouchani M, Aboulazm D, Karkouri M, Eissa S, Pfeiffer RM, ... ... Merajver SD, et al. Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa. Breast Cancer Research and Treatment. PMID 31006821 DOI: 10.1007/S10549-019-05237-5  0.491
2019 Oliver CR, Altemus MA, Westerhof TM, Cheriyan H, Cheng X, Dziubinski M, Wu Z, Yates J, Morikawa A, Heth J, Castro MG, Leung BM, Takayama S, Merajver SD. A platform for artificial intelligence based identification of the extravasation potential of cancer cells into the brain metastatic niche. Lab On a Chip. PMID 30810557 DOI: 10.1039/C8Lc01387J  0.442
2019 Chen W, Allen SG, Qian W, Peng Z, Han S, Li X, Sun Y, Fournier C, Bao L, Lam RHW, Merajver SD, Fu J. Biophysical Phenotyping and Modulation of ALDH+ Inflammatory Breast Cancer Stem-Like Cells. Small (Weinheim An Der Bergstrasse, Germany). e1802891. PMID 30632269 DOI: 10.1002/Smll.201802891  0.547
2019 McCain L, Milliron KJ, Cook A, Schroeder L, Arthurs J, Harper DM, Ernst S, Zazove P, Parvaz JD, Keren D, Merajver S. Test of InheRET, an online tool to facilitate NCCN Guideline compliant referrals for cancer genetic counseling. Journal of Clinical Oncology. 37: 1530-1530. DOI: 10.1200/Jco.2019.37.15_Suppl.1530  0.391
2019 Bhatia S, Palomares M, Hageman L, Chen Y, Landier W, Smith K, Umphrey H, Reich CA, Zamora KW, Armenian SH, Bevers TB, Blaes A, Henderson TO, Hodgson DC, Hudson MM, ... ... Merajver S, et al. Low-Dose Tamoxifen (LDTam) As a Breast Cancer (BC) Risk-Reduction Strategy in Lymphoma Survivors Exposed to Chest Radiation Therapy (RT) during Adolescence/Young Adulthood - a Randomized, Placebo-Controlled Double Blinded Phase IIb Trial Blood. 134: 2843-2843. DOI: 10.1182/Blood-2019-126661  0.39
2019 Morikawa A, Robinson, Soellner M, Wu Y, Lonigro R, Gilani R, Cheng X, Lachacz E, Thomas D, McMurray K, Smerage J, Henry N, Heth J, Chinnaiyan A, Hayes D, ... Merajver S, et al. Abstract PD9-12: Integrative molecular profiling of breast cancer brain metastasis and patient-derived xenograft organoids from resected breast cancer brain metastases to interrogate and prioritize therapeutic personalized strategies Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-Pd9-12  0.499
2019 Little AC, Pathanjeli P, Wu Z, Bao L, Goo L, Yates JA, Merajver SD. Abstract 4518: IL-4/IL-13 stimulated tumor-associated macrophages enhance breast cancer cell invasion through Rho-GTPase signaling Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-4518  0.418
2019 Goo LE, Yates JA, Little AC, Kremer D, Kovalenko I, Oliver CR, Westerhof T, Wu Z, Vandecan N, Bao L, Ulintz PJ, Lyssiotis CA, Merajver SD. Abstract 4363: Effects of the small GTPase RhoC on inflammatory breast cancer metabolism Cancer Research. 79: 4363-4363. DOI: 10.1158/1538-7445.Sabcs18-4363  0.582
2019 Merrill NM, Vandecan NM, Lloyd JP, Lachacz EJ, Ulintz PJ, Merajver SD, Soellner MB. Abstract 3989: Identification of biomarkers for UM-164 in triple-negative breast cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-3989  0.555
2018 Nikolaidis C, Duquette D, Mendelsohn-Victor KE, Anderson B, Copeland G, Milliron KJ, Merajver SD, Janz NK, Northouse LL, Duffy SA, Katapodi MC. Disparities in genetic services utilization in a random sample of young breast cancer survivors. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 30385886 DOI: 10.1038/S41436-018-0349-1  0.485
2018 Jiagge E, Jibril AS, Davis M, Murga-Zamalloa C, Kleer CG, Gyan K, Divine G, Hoenerhoff M, Bensenhave J, Awuah B, Oppong J, Adjei E, Salem B, Toy K, Merajver S, et al. Androgen Receptor and ALDH1 Expression Among Internationally Diverse Patient Populations. Journal of Global Oncology. 1-8. PMID 30307804 DOI: 10.1200/Jgo.18.00056  0.433
2018 Kaushal N, Tiruchinapally G, Durmaz YY, Bao L, Gilani R, Merajver SD, ElSayed MEH. Synergistic inhibition of aggressive breast cancer cell migration and invasion by cytoplasmic delivery of anti-RhoC silencing RNA and presentation of EPPT1 peptide on "smart" particles. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30149048 DOI: 10.1016/J.Jconrel.2018.07.042  0.533
2018 Luo M, Shang L, Brooks MD, Jiagge E, Zhu Y, Buschhaus JM, Conley S, Fath MA, Davis A, Gheordunescu E, Wang Y, Harouaka R, Lozier A, Triner D, McDermott S, ... Merajver SD, et al. Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling. Cell Metabolism. 28: 69-86.e6. PMID 29972798 DOI: 10.1016/J.Cmet.2018.06.006  0.384
2018 Katapodi MC, Jung M, Schafenacker AM, Milliron KJ, Mendelsohn-Victor KE, Merajver SD, Northouse LL. Development of a Web-based Family Intervention for BRCA Carriers and Their Biological Relatives: Acceptability, Feasibility, and Usability Study. Jmir Cancer. 4: e7. PMID 29653920 DOI: 10.2196/Cancer.9210  0.395
2018 Hadgu E, Seifu D, Tigneh W, Bokretsion Y, Bekele A, Abebe M, Sollie T, Merajver SD, Karlsson C, Karlsson MG. Breast cancer in Ethiopia: evidence for geographic difference in the distribution of molecular subtypes in Africa. Bmc Women's Health. 18: 40. PMID 29444670 DOI: 10.1186/S12905-018-0531-2  0.536
2018 Jones T, Duquette D, Underhill M, Ming C, Mendelsohn-Victor KE, Anderson B, Milliron KJ, Copeland G, Janz NK, Northouse LL, Duffy SM, Merajver SD, Katapodi MC. Surveillance for cancer recurrence in long-term young breast cancer survivors randomly selected from a statewide cancer registry. Breast Cancer Research and Treatment. PMID 29353367 DOI: 10.1007/S10549-018-4674-5  0.558
2018 Merajver S, Phadke S, Soellner M. Conquering the challenges of genotypic and phenotypic tumor heterogeneity to realize the promise of personalized cancer therapy: the role of academia. Transactions of the American Clinical and Climatological Association. 128: 169-179. PMID 28790501  0.386
2018 Jiagge E, Bensenhaver J, Celina K, Hoenerhoff M, Gilani R, Kyei I, Oppong J, Awuah B, Adjei E, Wicha M, Newman L, Merajver S. Creating Models to Identify New Therapeutic Options for Aggressive African Breast Cancers Journal of Global Oncology. 4: 206s-206s. DOI: 10.1200/Jgo.18.83500  0.502
2018 Jiagge EM, Oppong JK, Harvey K, Bensenhaver JM, Adjei E, Cheng X, Ulintz P, Gyan KK, Salem B, Kyei I, Awuah B, Wicha M, Newman LA, Merajver S. Biologic diversity of breast cancers in women with African ancestry. Journal of Clinical Oncology. 36: e13114-e13114. DOI: 10.1200/Jco.2018.36.15_Suppl.E13114  0.464
2018 Gilani R, Lachacz E, Bao LW, Phadke S, Soellner M, Merajver S. Rational drug combination therapy for improved efficacy and delayed resistance in triple negative breast cancer. Journal of Clinical Oncology. 36: e13113-e13113. DOI: 10.1200/Jco.2018.36.15_Suppl.E13113  0.375
2018 Milliron KJ, Prince V, Hipp L, Uppal S, Brackmann M, Reynolds RK, Merajver S, McLean K. Implementation of strategies to increase genetic counseling referral rates for ovarian cancer patients. Journal of Clinical Oncology. 36: 1590-1590. DOI: 10.1200/Jco.2018.36.15_Suppl.1590  0.385
2018 Luo M, Shang L, Brooks M, Jiagge E, Zhu Y, Conley S, Fath M, Harouaka R, Merajver S, Spitz, Wicha. Abstract P1-02-09: Targeting breast cancer stem cell state equilibrium through modulation of redox signaling Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P1-02-09  0.448
2018 Cheriyan H, Wu Z, Yates J, Merajver SD. Abstract 5156: RhoC decreases tight junction stabilization in breast cancer cells, revealing a potential therapeutic target Cancer Research. 78: 5156-5156. DOI: 10.1158/1538-7445.Am2018-5156  0.578
2018 Oliver CR, Altemus M, Westerhof T, Morikawa A, Cheng X, Heth J, Takayama S, Castro M, Merajver S. Abstract 3103: Analysis of breast cancer lines and PDXs using a blood brain niche (µm-BBN) microfluidic device and algorithms to aid diagnosis of brain metastatic potential Cancer Research. 78: 3103-3103. DOI: 10.1158/1538-7445.Am2018-3103  0.463
2018 Caceres S, Little AC, Yates JA, Gilani RA, Merajver SD. Abstract 2044: Lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1) modulates VEGF-C and VEGF-D secretion in the triple negative breast cancer cell line MDA-MB-231 Tumor Biology. DOI: 10.1158/1538-7445.Am2018-2044  0.428
2018 Goo LE, Yates JA, Bao L, Wu Z, Merajver SD. Abstract 1444: RhoC regulation of inflammatory breast cancer metabolism Cancer Research. 78: 1444-1444. DOI: 10.1158/1538-7445.Am2018-1444  0.555
2017 Woodward WA, Cristofanilli M, Merajver SD, Van Laere S, Pusztai L, Bertucci F, Berditchevski F, Polyak K, Overmoyer B, Devi GR, Sterneck E, Schneider R, Debeb BG, Wang X, van Golen KL, et al. Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10 Anniversary Conference. Journal of Cancer. 8: 3607-3614. PMID 29667990 DOI: 10.7150/Jca.21200  0.429
2017 Thomas AS, Kidwell KM, Oppong JK, Adjei EK, Osei-Bonsu E, Boahene A, Jiggae E, Gyan K, Merajver SD. Breast Cancer in Ghana: Demonstrating the Need for Population-Based Cancer Registries in Low- and Middle-Income Countries. Journal of Global Oncology. 3: 765-772. PMID 29244986 DOI: 10.1200/Jgo.2016.006098  0.522
2017 Aw Yong KM, Li Z, Merajver SD, Fu J. Tracking the tumor invasion front using long-term fluidic tumoroid culture. Scientific Reports. 7: 10784. PMID 28883652 DOI: 10.1038/S41598-017-10874-1  0.336
2017 Aw Yong KM, Sun Y, Merajver SD, Fu J. Mechanotransduction-Induced Reversible Phenotypic Switching in Prostate Cancer Cells. Biophysical Journal. 112: 1236-1245. PMID 28355550 DOI: 10.1016/J.Bpj.2017.02.012  0.438
2017 Le L, Schairer C, Hablas A, Meza J, Watanabe-Galloway S, Ramadan M, Merajver SD, Seifeldin IA, Soliman AS. Reliability of medical records in diagnosing inflammatory breast cancer in Egypt. Bmc Research Notes. 10: 126. PMID 28302157 DOI: 10.1186/S13104-017-2433-Z  0.484
2017 Katapodi MC, Duquette D, Yang JJ, Mendelsohn-Victor K, Anderson B, Nikolaidis C, Mancewicz E, Northouse LL, Duffy S, Ronis D, Milliron KJ, Probst-Herbst N, Merajver SD, Janz NK, Copeland G, et al. Recruiting families at risk for hereditary breast and ovarian cancer from a statewide cancer registry: a methodological study. Cancer Causes & Control : Ccc. PMID 28197806 DOI: 10.1007/S10552-017-0858-2  0.549
2017 Daly MB, Pilarski R, Berry M, Buys SS, Farmer M, Friedman S, Garber JE, Kauff ND, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, Merajver SD, et al. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017. Journal of the National Comprehensive Cancer Network : Jnccn. 15: 9-20. PMID 28040716 DOI: 10.6004/Jnccn.2017.0003  0.453
2017 Jiagge EM, Jibril A, Divine G, Gyan KK, Bensenhaver JM, Oppong JK, Awuah B, Adjei E, Merajver S, Wicha M, Newman LA. Beyond triple-negative breast cancer and African ancestry: Tumor phenotypes among internationally diverse patient populations. Journal of Clinical Oncology. 35: 1101-1101. DOI: 10.1200/Jco.2017.35.15_Suppl.1101  0.535
2017 Yong KMA, Oliver C, Altemus M, Wu ZF, Merajver S. Abstract 5769: Modeling the tumor invasion front using 3D fluidic tumoroid culture of cancer cells Cancer Research. 77: 5769-5769. DOI: 10.1158/1538-7445.Am2017-5769  0.414
2017 Luo M, Shang L, Brooks M, Jiagge E, Conley S, Harouaka R, Zhu Y, Merajver SD, Spitz DR, Wicha MS. Abstract 4785: Disrupting redox regulated cancer stem cell state equilibrium by co-inhibition of glycolysis and thioredoxin/glutathione antioxidant pathways Cancer Research. 77: 4785-4785. DOI: 10.1158/1538-7445.Am2017-4785  0.387
2017 Altemus M, Yates J, Wu Z, Bao L, Merajver S. Abstract 433: Glycogen accumulation in aggressive breast cancers during hypoxic exposure Cancer Research. 77: 433-433. DOI: 10.1158/1538-7445.Am2017-433  0.525
2017 Gilani RA, Lachacz EJ, Phadke S, Bao LW, Cheng X, Jiagge EM, Soellner MB, Merajver SD. Abstract 4117: Mechanisms of acquired resistance to c-Src kinase inhibitor in triple negative breast cancer Cancer Research. 77: 4117-4117. DOI: 10.1158/1538-7445.Am2017-4117  0.461
2017 Jiagge EM, Wong S, Gilani R, Mcdermott S, Newman L, Bensenhaver J, Wicha M, Carpten J, Merajver S. Abstract 3371: Aldh expressing stem cells mediate tumor initiation and metastasis in triple negative breast cancers across different ethnicities Cancer Research. 77: 3371-3371. DOI: 10.1158/1538-7445.Am2017-3371  0.53
2016 Jiagge E, Oppong JK, Bensenhaver J, Aitpillah F, Gyan K, Kyei I, Osei-Bonsu E, Adjei E, Ohene-Yeboah M, Toy K, Jackson KE, Akpaloo M, Acheampong D, Antwi B, Agyeman FO, ... ... Merajver S, et al. Breast Cancer and African Ancestry: Lessons Learned at the 10-Year Anniversary of the Ghana-Michigan Research Partnership and International Breast Registry. Journal of Global Oncology. 2: 302-310. PMID 28717716 DOI: 10.1200/Jgo.2015.002881  0.551
2016 Allen SG, Chen YC, Madden JM, Fournier CL, Altemus MA, Hiziroglu AB, Cheng YH, Wu ZF, Bao L, Yates JA, Yoon E, Merajver SD. Macrophages Enhance Migration in Inflammatory Breast Cancer Cells via RhoC GTPase Signaling. Scientific Reports. 6: 39190. PMID 27991524 DOI: 10.1038/Srep39190  0.574
2016 Cobain EF, Milliron KJ, Merajver SD. Updates on breast cancer genetics: Clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer. Seminars in Oncology. 43: 528-535. PMID 27899183 DOI: 10.1053/J.Seminoncol.2016.10.001  0.562
2016 Chen W, Allen SG, Reka AK, Qian W, Han S, Zhao J, Bao L, Keshamouni VG, Merajver SD, Fu J. Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics. Bmc Cancer. 16: 614. PMID 27501846 DOI: 10.1186/S12885-016-2638-X  0.391
2016 Jiagge E, Jibril AS, Chitale D, Bensenhaver JM, Awuah B, Hoenerhoff M, Adjei E, Bekele M, Abebe E, Nathanson SD, Gyan K, Salem B, Oppong J, Aitpillah F, Kyei I, ... ... Merajver SD, et al. Comparative Analysis of Breast Cancer Phenotypes in African American, White American, and West Versus East African patients: Correlation Between African Ancestry and Triple-Negative Breast Cancer. Annals of Surgical Oncology. PMID 27469125 DOI: 10.1245/S10434-016-5420-Z  0.53
2016 Wynn M, Kidwell KM, Merajver SD. The Impact of Nathan Mantel's "The Detection of Disease Clustering and a Generalized Regression Approach". Cancer Research. 76: 2495-2496. PMID 27197259 DOI: 10.1158/0008-5472.Can-16-0883  0.4
2016 Gilani R, Phadke S, Bao LW, Lachacz E, Dziubinski M, Brandvold K, Steffey M, Kwarcinski F, Graveel CR, Kidwell KM, Merajver SD, Soellner MB. UM-164: a potent c-Src/p38 kinase inhibitor with in vivo activity against triple negative breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27154914 DOI: 10.1158/1078-0432.Ccr-15-2158  0.39
2016 Wynn ML, Yates JA, Evans CR, Van Wassenhove L, Wu ZF, Bridges S, Bao L, Fournier C, Ashrafzadeh S, Merrins MJ, Satin LS, Schnell S, Burant CF, Merajver SD. RhoC is a Potent Regulator of Glutamine Metabolism and N-acetylaspartate Production in Inflammatory Breast Cancer Cells. The Journal of Biological Chemistry. PMID 27129239 DOI: 10.1074/Jbc.M115.703959  0.525
2016 Jones T, Lockhart JS, Mendelsohn-Victor KE, Duquette D, Northouse LL, Duffy SA, Donley R, Merajver SD, Milliron KJ, Roberts JS, Katapodi MC. Use of Cancer Genetics Services in African-American Young Breast Cancer Survivors. American Journal of Preventive Medicine. PMID 27117712 DOI: 10.1016/J.Amepre.2016.03.016  0.55
2016 Murthy P, Kidwell KM, Schott AF, Merajver SD, Griggs JJ, Smerage JD, Van Poznak CH, Wicha MS, Hayes DF, Henry NL. Clinical predictors of long-term survival in HER2-positive metastatic breast cancer. Breast Cancer Research and Treatment. PMID 26875184 DOI: 10.1007/S10549-016-3705-3  0.4
2016 Daly MB, Pilarski R, Axilbund JE, Berry M, Buys SS, Crawford B, Farmer M, Friedman S, Garber JE, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, ... ... Merajver SD, et al. Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015. Journal of the National Comprehensive Cancer Network : Jnccn. 14: 153-62. PMID 26850485 DOI: 10.6004/Jnccn.2016.0018  0.451
2016 Hosmer A, Merajver S, Stoffel E, Milliron K, Kwon R, Elta G, Scheiman J, Anderson M, Menees SB. EUS and MRI/MRCP Findings in Pancreatic Cancer Screening for Individuals Who Harbor a BRCA2 Deleterious Germline Mutation: 31 The American Journal of Gastroenterology. 111. DOI: 10.14309/00000434-201610001-00031  0.359
2016 Newman L, Jiagge E, Bensenhaver J, Chitale D, Kleer C, Merajver S, Kyei I, Aitpillah F, Oppong J, Amankwaa-Frempong E, Adjei E, Wicha M, Awuah B, Stark A. Abstract P6-12-14: Comparative analysis of breast cancer phenotypes in African American, White American, and African patients- Correlation between African ancestry and triple negative breast cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P6-12-14  0.521
2016 Madden J, Allen S, Shen Y, Fournier C, Wu Z, Bao L, Merajver S. Abstract 3236: Macrophages increase the expression of RhoC in inflammatory breast cancer leading to increased migration Cancer Research. 76: 3236-3236. DOI: 10.1158/1538-7445.Am2016-3236  0.533
2016 Altemus M, Leung B, Morikawa A, Dziubinski M, Castro M, Merajver S. Abstract 1700: Novel microfluidic blood-brain niche to study breast cancer metastasis to the brain Cancer Research. 76: 1700-1700. DOI: 10.1158/1538-7445.Am2016-1700  0.397
2016 Yates JA, Altemus M, Wu Z, Wynn ML, Merajver SD. Abstract 1040: Differential levels of glycogen in breast cancer cell lines: A potential new target Cancer Research. 76: 1040-1040. DOI: 10.1158/1538-7445.Am2016-1040  0.559
2015 Der EM, Gyasi RK, Tettey Y, Edusei L, Bayor MT, Jiagge E, Gyakobo M, Merajver SD, Newman LA. Triple-Negative Breast Cancer in Ghanaian Women: The Korle Bu Teaching Hospital Experience. The Breast Journal. 21: 627-33. PMID 26547900 DOI: 10.1111/Tbj.12527  0.558
2015 Schlichting JA, Soliman AS, Schairer C, Harford JB, Hablas A, Ramadan M, Seifeldin I, Merajver SD. Breast Cancer by Age at Diagnosis in the Gharbiah, Egypt, Population-Based Registry Compared to the United States Surveillance, Epidemiology, and End Results Program, 2004-2008. Biomed Research International. 2015: 381574. PMID 26495294 DOI: 10.1155/2015/381574  0.504
2015 Song Q, Merajver SD, Li JZ. Cancer classification in the genomic era: five contemporary problems. Human Genomics. 9: 27. PMID 26481255 DOI: 10.1186/S40246-015-0049-8  0.499
2015 Bevers TB, Ward JH, Arun BK, Colditz GA, Cowan KH, Daly MB, Garber JE, Gemignani ML, Gradishar WJ, Jordan JA, Korde LA, Kounalakis N, Krontiras H, Kumar S, Kurian A, ... ... Merajver SD, et al. Breast Cancer Risk Reduction, Version 2.2015. Journal of the National Comprehensive Cancer Network : Jnccn. 13: 880-915. PMID 26150582 DOI: 10.6004/Jnccn.2015.0105  0.556
2015 Kaushal N, Durmaz YY, Bao L, Merajver SD, ElSayed ME. "Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells. Molecular Pharmaceutics. 12: 2406-17. PMID 26020100 DOI: 10.1021/Acs.Molpharmaceut.5B00114  0.561
2015 Chen YC, Allen SG, Ingram PN, Buckanovich R, Merajver SD, Yoon E. Single-cell Migration Chip for Chemotaxis-based Microfluidic Selection of Heterogeneous Cell Populations. Scientific Reports. 5: 9980. PMID 25984707 DOI: 10.1038/Srep09980  0.426
2015 Proctor E, Kidwell KM, Jiagge E, Bensenhaver J, Awuah B, Gyan K, Toy K, Oppong JK, Kyei I, Aitpillah F, Osei-Bonsu E, Adjei E, Ohene-Yeboah M, Brewer RN, Fondjo LA, ... ... Merajver S, et al. Characterizing Breast Cancer in a Population with Increased Prevalence of Triple-Negative Breast Cancer: Androgen Receptor and ALDH1 Expression in Ghanaian Women. Annals of Surgical Oncology. 22: 3831-5. PMID 25743329 DOI: 10.1245/S10434-015-4455-X  0.561
2015 Goldman P, Prochaska E, Stacey I, Miller A, Merajver S, Mosquera J, Lai Z, Grunauer M, G McInnis M. Depression Risk and Cancer in Ecuador: The Protective Role of Social Support Mental Health in Family Medicine. 11. DOI: 10.25149/1756-8358.1102010  0.314
2015 Murthy P, Kidwell KM, Thomas DG, Griggs JJ, Merajver SD, Schott AF, Smerage JB, Poznak CHV, Wicha M, Hayes DF, Henry NL. Abstract P6-08-50: Clinical predictors of long-term survival in Her2-positive (HER2+) metastatic breast cancer (MBC) Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P6-08-50  0.494
2015 Le L, Schairer C, Hablas A, Ramadan M, Merajver S, Seifeldein I, Soliman A. Abstract 5590: Reliability of medical records in diagnosing inflammatory breast cancer in Egypt Cancer Research. 75: 5590-5590. DOI: 10.1158/1538-7445.Am2015-5590  0.429
2015 Gilani RA, Brandvold KR, Bao LW, Phadke S, Steffey ME, Soellner MB, Merajver SD. Abstract 5536: KB-164, a novel and highly potent Src family kinase inhibitor, reduces cancer cell invasion and abrogates downstream oncogenic pathways in triple negative breast cancer Cancer Research. 75: 5536-5536. DOI: 10.1158/1538-7445.Am2015-5536  0.539
2015 Azizi E, Jiagge EM, Fouladdel S, Wong S, Dziubinski ML, Sehl M, Kyani A, Li J, Jiang H, Luther TK, Clouthier SG, McDermott SP, Carpten J, Newman LA, Merajver SD, et al. Abstract 4834: Single cell multiplex gene expression analysis to unravel heterogeneity of PDX samples established from tumors of breast cancer patients with different ethnicity Cancer Research. 75: 4834-4834. DOI: 10.1158/1538-7445.Am2015-4834  0.518
2015 Jiagge EM, Wong S, Lupu G, Qiao M, Dziubinski M, Newman LA, Carpten J, Wicha M, Merajver SD. Abstract 3852: Prevalent loss of BRCA1 and BRCA2 expression in African TNBC suggests their prominent role in sporadic carcinogenesis Cancer Research. 75: 3852-3852. DOI: 10.1158/1538-7445.Am2015-3852  0.485
2015 Jiagge EM, Song Q, Wong S, Luther T, Dziubinski M, Clouthier S, McDermott S, Newman L, Carpten J, Li J, WIcha M, Merajver S. Abstract 1518: Multiethnic triple negative breast cancer comparisons of gene expression shows enrichment of distinct pathways in ALDH1+ subpopulations compared to CD44+/CD24-/EpCAM+ Cancer Research. 75: 1518-1518. DOI: 10.1158/1538-7445.Am2015-1518  0.406
2015 Yates JA, Wynn ML, Wu Z, Evans CR, Burant C, Schnell SD, Merajver SD. Abstract 1203: Metastasis-associated oncogene RhoC as a regulator of glutamine metabolism in the inflammatory breast cancer cell line SUM149 Cancer Research. 75: 1203-1203. DOI: 10.1158/1538-7445.Am2015-1203  0.564
2015 Kaushal N, Durmaz YY, Bao L, Merajver SD, ElSayed MEH. "Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells Molecular Pharmaceutics. 12: 2406-2417. DOI: 10.1021/acs.molpharmaceut.5b00114  0.367
2015 Pilie PG, Milliron KJ, Merajver SD. DCIS and hereditary susceptibility for breast cancer Ductal Carcinoma in Situ and Microinvasive/Borderline Breast Cancer. 147-154. DOI: 10.1007/978-1-4939-2035-8_15  0.418
2014 Meernik C, Soliman AS, Ngoma T, Kahesa C, Mwaiselage J, Merajver SD. The changing pattern of ano-rectal cancer, squamous cell carcinoma of the eye, and Hodgkin's lymphoma as non-AIDS-defining cancers, by HIV status, in Tanzania over 11 years (2002-2012): a retrospective case-report study. Infectious Agents and Cancer. 9: 42. PMID 25926865 DOI: 10.1186/1750-9378-9-42  0.358
2014 Wynn ML, Consul N, Merajver SD, Schnell S. Inferring the Effects of Honokiol on the Notch Signaling Pathway in SW480 Colon Cancer Cells. Cancer Informatics. 13: 1-12. PMID 25392689 DOI: 10.4137/Cin.S14060  0.444
2014 Obrist M, Osei-Bonsu E, Awuah B, Watanabe-Galloway S, Merajver SD, Schmid K, Soliman AS. Factors related to incomplete treatment of breast cancer in Kumasi, Ghana. Breast (Edinburgh, Scotland). 23: 821-8. PMID 25282667 DOI: 10.1016/J.Breast.2014.08.014  0.536
2014 Daly MB, Pilarski R, Axilbund JE, Buys SS, Crawford B, Friedman S, Garber JE, Horton C, Kaklamani V, Klein C, Kohlmann W, Kurian A, Litton J, Madlensky L, Marcom PK, ... Merajver SD, et al. Genetic/familial high-risk assessment: breast and ovarian, version 1.2014. Journal of the National Comprehensive Cancer Network : Jnccn. 12: 1326-38. PMID 25190698 DOI: 10.6004/Jnccn.2014.0127  0.416
2014 Scherber S, Soliman AS, Awuah B, Osei-Bonsu E, Adjei E, Abantanga F, Merajver SD. Characterizing breast cancer treatment pathways in Kumasi, Ghana from onset of symptoms to final outcome: outlook towards cancer control. Breast Disease. 34: 139-49. PMID 24934170 DOI: 10.3233/Bd-140372  0.549
2014 Hirko KA, Soliman AS, Banerjee M, Ruterbusch J, Harford JB, Merajver SD, Schwartz K. A comparison of criteria to identify inflammatory breast cancer cases from medical records and the Surveillance, Epidemiology and End Results data base, 2007-2009. The Breast Journal. 20: 185-91. PMID 24372839 DOI: 10.1111/Tbj.12234  0.515
2014 Jiagge EM, Oppong JK, Awuah B, Newman LA, Wicha M, Merajver S. Characteristics of breast cancer in Ghana and prevalence of aggressive disease and high mortality. Journal of Clinical Oncology. 32: 596-596. DOI: 10.1200/Jco.2014.32.15_Suppl.596  0.475
2014 Jiagge EM, Bensenhaver J, McDermott S, Baffour A, Wicha M, Newman LA, Merajver S. Abstract PL03-03: Differences in breast cancer stem cell signaling and metabolic integration associated with African versus European ancestry Cancer Epidemiology, Biomarkers & Prevention. 23. DOI: 10.1158/1538-7755.Disp13-Pl03-03  0.537
2014 Jiagge EM, Wong S, Luthur T, McDermott S, Clouthier S, Kurdoglu A, Aldrich J, Merajver S, Craig D, Trent J, Newman L, LoRusso P, Wicha M, Carpten J. Abstract LB-59: Distinct pathways differentiate the CD44+ mesenchymal-like from the ALDH+ epithelial-like phenotype of triple negative breast cancer stem cells Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-59  0.416
2014 Allen SG, Oltean H, Toy K, Omar OS, Youssef T, Karkouri M, Abdel-Aziz A, Hablas A, Tahri A, Kleer C, Soliman A, Merajver SD. Abstract 4977: Chronic mastitis in North Africa: Geographic overlap and a potential precursor comorbidity of inflammatory breast cancer Cancer Research. 74: 4977-4977. DOI: 10.1158/1538-7445.Am2014-4977  0.499
2014 Egbert ME, Wynn ML, Wu ZF, Gilani RA, Schnell S, Merajver SD. Abstract 357: A systems biology approach for rational molecular network inference Cancer Research. 74: 357-357. DOI: 10.1158/1538-7445.Am2014-357  0.364
2014 Fournier CL, Allen SG, Chen Y, Yoon E, Merajver SD. Abstract 1179: Macrophage conditioned media increases the expression of a metastasis-associated oncogene, RhoC, and the migration of inflammatory breast cancer cells Cancer Research. 74: 1179-1179. DOI: 10.1158/1538-7445.Am2014-1179  0.552
2013 Oltean HN, Soliman AS, Omar OS, Youssef TF, Karkouri M, Abdel-Aziz A, Hablas A, Blachley T, Tahri A, Merajver SD. Risk factors for chronic mastitis in morocco and egypt. International Journal of Inflammation. 2013: 184921. PMID 24327928 DOI: 10.1155/2013/184921  0.355
2013 Hirko KA, Soliman AS, Hablas A, Seifeldin IA, Ramadan M, Banerjee M, Harford JB, Chamberlain RM, Merajver SD. Trends in Breast Cancer Incidence Rates by Age and Stage at Diagnosis in Gharbiah, Egypt, over 10 Years (1999-2008). Journal of Cancer Epidemiology. 2013: 916394. PMID 24282410 DOI: 10.1155/2013/916394  0.533
2013 Perng P, Perng W, Ngoma T, Kahesa C, Mwaiselage J, Merajver SD, Soliman AS. Promoters of and barriers to cervical cancer screening in a rural setting in Tanzania. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. 123: 221-5. PMID 24095307 DOI: 10.1016/J.Ijgo.2013.05.026  0.332
2013 O'Brien KS, Soliman AS, Awuah B, Jiggae E, Osei-Bonsu E, Quayson S, Adjei E, Thaivalappil SS, Abantanga F, Merajver SD. Establishing effective registration systems in resource-limited settings: cancer registration in Kumasi, Ghana. Journal of Registry Management. 40: 70-7. PMID 24002131  0.386
2013 Akinyemiju TF, Soliman AS, Copeland G, Banerjee M, Schwartz K, Merajver SD. Trends in breast cancer stage and mortality in Michigan (1992-2009) by race, socioeconomic status, and area healthcare resources. Plos One. 8: e61879. PMID 23637921 DOI: 10.1371/Journal.Pone.0061879  0.436
2013 Schairer C, Soliman AS, Omar S, Khaled H, Eissa S, Ayed FB, Khalafallah S, Ayoub WB, Kantor ED, Merajver S, Swain SM, Gail M, Brown LM. Assessment of diagnosis of inflammatory breast cancer cases at two cancer centers in Egypt and Tunisia. Cancer Medicine. 2: 178-84. PMID 23634285 DOI: 10.1002/Cam4.48  0.485
2013 Akinyemiju TF, Soliman AS, Johnson NJ, Altekruse SF, Welch K, Banerjee M, Schwartz K, Merajver S. Individual and neighborhood socioeconomic status and healthcare resources in relation to black-white breast cancer survival disparities. Journal of Cancer Epidemiology. 2013: 490472. PMID 23509460 DOI: 10.1155/2013/490472  0.494
2013 Katapodi MC, Northouse LL, Schafenacker AM, Duquette D, Duffy SA, Ronis DL, Anderson B, Janz NK, McLosky J, Milliron KJ, Merajver SD, Duong LM, Copeland G. Using a state cancer registry to recruit young breast cancer survivors and high-risk relatives: protocol of a randomized trial testing the efficacy of a targeted versus a tailored intervention to increase breast cancer screening. Bmc Cancer. 13: 97. PMID 23448100 DOI: 10.1186/1471-2407-13-97  0.55
2013 Hirko KA, Soliman AS, Banerjee M, Ruterbusch J, Harford JB, Chamberlain RM, Graff JJ, Merajver SD, Schwartz K. Characterizing inflammatory breast cancer among Arab Americans in the California, Detroit and New Jersey Surveillance, Epidemiology and End Results (SEER) registries (1988-2008). Springerplus. 2: 3. PMID 23420611 DOI: 10.1186/2193-1801-2-3  0.469
2013 Chen W, Weng S, Zhang F, Allen S, Li X, Bao L, Lam RH, Macoska JA, Merajver SD, Fu J. Nanoroughened surfaces for efficient capture of circulating tumor cells without using capture antibodies. Acs Nano. 7: 566-75. PMID 23194329 DOI: 10.1021/Nn304719Q  0.395
2013 Katapodi MC, Northouse LL, Milliron KJ, Liu G, Merajver SD. Individual and family characteristics associated with BRCA1/2 genetic testing in high-risk families. Psycho-Oncology. 22: 1336-43. PMID 22826208 DOI: 10.1002/Pon.3139  0.367
2013 Hain JZ, Mange S, Bach J, Duquette D, McLosky J, Dohany L, Roberson J, Biro K, Petrucelli N, Iacoboni D, Ahsan S, Merajver S, Milliron KJ, Everett J, Zakalik D. Assessment of cancer screening practices after BRCA testing in Michigan. Journal of Clinical Oncology. 31: 1557-1557. DOI: 10.1200/Jco.2013.31.15_Suppl.1557  0.465
2013 Wynn ML, Egbert M, Wassenhove LDV, Wu ZF, Midani F, Evans C, Burant CF, Schnell S, Merajver SD. Abstract 5239: Unraveling the complex regulatory relationship between PI3K signaling and metabolic transformation in breast cancer. Cancer Research. 73: 5239-5239. DOI: 10.1158/1538-7445.Am2013-5239  0.518
2013 Ashrafzadeh S, Wassenhove LDV, Merajver SD. Abstract 1695: Quantification of mitochondria in MCF-10A, MDA-MB-231, and SUM149 cells to understand potential defects in oxidative phosphorylation in cancer. Cancer Research. 73: 1695-1695. DOI: 10.1158/1538-7445.Am2013-1695  0.518
2012 Chang J, Patel I, Tan X, Merajver S, Balkrishnan R. PCN12 Meta Analytic Comparison of Breast Cancer Risk in Diabetic Women: Important Differences Between Asian and Caucasian Women Suggest Risk Management Startegies. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 15: A655. PMID 27205715 DOI: 10.1016/J.Jval.2012.08.310  0.387
2012 Rosenthal DT, Zhang J, Bao L, Zhu L, Wu Z, Toy K, Kleer CG, Merajver SD. RhoC impacts the metastatic potential and abundance of breast cancer stem cells. Plos One. 7: e40979. PMID 22911725 DOI: 10.1371/Journal.Pone.0040979  0.832
2012 Schlichting JA, Soliman AS, Schairer C, Schottenfeld D, Merajver SD. Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990-2008. Breast Cancer Research and Treatment. 134: 1257-68. PMID 22733221 DOI: 10.1007/S10549-012-2133-2  0.389
2012 O'Brien KS, Soliman AS, Annan K, Lartey RN, Awuah B, Merajver SD. Traditional herbalists and cancer management in Kumasi, Ghana. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. 27: 573-9. PMID 22549472 DOI: 10.1007/S13187-012-0370-Z  0.471
2012 Rosenthal DT, Merajver SD. Rethinking the war on cancer: multidisciplinary collaborations between biologists and physical scientists. Future Oncology (London, England). 8: 339-41. PMID 22515435 DOI: 10.2217/Fon.12.13  0.77
2012 Akinyemiju TF, Soliman AS, Yassine M, Banerjee M, Schwartz K, Merajver S. Healthcare access and mammography screening in Michigan: a multilevel cross-sectional study. International Journal For Equity in Health. 11: 16. PMID 22436125 DOI: 10.1186/1475-9276-11-16  0.421
2012 Wynn ML, Merajver SD, Schnell S. Unraveling the complex regulatory relationships between metabolism and signal transduction in cancer. Advances in Experimental Medicine and Biology. 736: 179-89. PMID 22161328 DOI: 10.1007/978-1-4419-7210-1_9  0.392
2012 Uddin N, Fateem E, Hablas A, Seifeldin IA, Brown E, Merajver SD, Soliman AS. Public and professional educational needs for downstaging breast cancer in Egypt. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. 27: 149-55. PMID 22057985 DOI: 10.1007/S13187-011-0282-3  0.526
2012 Schlichting JA, Soliman AS, Schairer C, Banerjee M, Rozek LS, Schottenfeld D, Harford JB, Merajver SD. Association of inflammatory and noninflammatory breast cancer with socioeconomic characteristics in the Surveillance, Epidemiology, and End Results database, 2000-2007. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 155-65. PMID 22028401 DOI: 10.1158/1055-9965.Epi-11-0833  0.48
2012 Merajver SD, Balkrishnan R. Making the case for integrated assessments of the biological, social, and system determinants of treatment for breast cancer to understand and improve outcomes in patients everywhere. Current Medical Research and Opinion. 28: 415-7. PMID 21995647 DOI: 10.1185/03007995.2011.628650  0.395
2012 Alford SH, Toy K, Merajver SD, Kleer CG. Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression. Breast Cancer Research and Treatment. 132: 429-37. PMID 21614565 DOI: 10.1007/S10549-011-1591-2  0.528
2012 Stanbery L, Petty EM, Merajver SD. Abstract 72: Amino terminus of SEPT9_i1 impacts cellular localization: Implications for mammary tumorigenesis Cancer Research. 72: 72-72. DOI: 10.1158/1538-7445.Am2012-72  0.434
2012 Shi CR, Rosenthal DT, Bao L, Pang JC, Wu Z, Allen SG, Merajver SD. Abstract 5622: Effect of novel RhoC inhibitor on breast cancer progression and metastasisin vivo Cancer Research. 72: 5622-5622. DOI: 10.1158/1538-7445.Am2012-5622  0.815
2012 Thaivalappil SS, Gyakobo M, Awuah B, Osei-Bonsu EB, Jiagge EM, Soliman AS, Merajver SD. Abstract 5511: Cancer care-seeking patterns in Kumasi, Ghana Cancer Research. 72: 5511-5511. DOI: 10.1158/1538-7445.Am2012-5511  0.425
2012 Wassenhove LDV, Wynn ML, Ashrafzadeh S, Merajver SD. Abstract 5164: Using metabolomic flux to uncover new targets for the modulation of breast cancer metastasis Cancer Research. 72: 5164-5164. DOI: 10.1158/1538-7445.Am2012-5164  0.576
2012 Wynn ML, Ventura AC, Sepulchre J, Garcia HJ, Merajver SD. Abstract 4925: The natural enzyme sequestration in signaling cascades provides inherent opportunities for off-target effects induced by kinase inhibitors Cancer Research. 72: 4925-4925. DOI: 10.1158/1538-7445.Am2012-4925  0.355
2012 Zhu L, Rosenthal DT, Zhang J, Bao L, Wu Z, Toy K, Kleer CG, Merajver SD. Abstract 2139: RhoC is a determinant of metastatic potential and affects the abundance of breast cancer stem cells Cancer Research. 72: 2139-2139. DOI: 10.1158/1538-7445.Am2012-2139  0.8
2012 Hirko KA, Soliman AS, Banerjee M, Ruterbusch J, Harford JB, Chamberlain R, Graff JJ, Merajver SD, Schwartz K. Abstract A61: Characterizing inflammatory breast cancer among Arab Americans in the California, Detroit, and New Jersey Surveillance, Epidemiology and End Results (SEER) registries (1988-2008). Cancer Epidemiology, Biomarkers & Prevention. 21. DOI: 10.1158/1055-9965.Disp12-A61  0.502
2012 Uddin N, Fateem E, Hablas A, Seifeldin IA, Brown E, Merajver SD, Soliman AS. Erratum to: Public and Professional Educational Needs for Downstaging Breast Cancer in Egypt Journal of Cancer Education. 27: 393-393. DOI: 10.1007/S13187-011-0289-9  0.427
2011 Soliman AS, Kleer CG, Mrad K, Karkouri M, Omar S, Khaled HM, Benider AL, Ayed FB, Eissa SS, Eissa MS, McSpadden EJ, Lo AC, Toy K, Kantor ED, Xiao Q, ... ... Merajver SD, et al. Inflammatory breast cancer in north Africa: comparison of clinical and molecular epidemiologic characteristics of patients from Egypt, Tunisia, and Morocco. Breast Disease. 33: 159-69. PMID 23001584 DOI: 10.3233/Bd-2012-000337  0.476
2011 Gilbert SF, Soliman AS, Karkouri M, Quinlan-Davidson M, Strahley A, Eissa M, Dey S, Hablas A, Seifeldin IA, Ramadan M, Benjaafar N, Toy K, Merajver SD. Clinical profile, BRCA2 expression, and the androgen receptor CAG repeat region in Egyptian and Moroccan male breast cancer patients. Breast Disease. 33: 17-26. PMID 22142662 DOI: 10.3233/Bd-2010-0323  0.404
2011 Katapodi MC, Northouse L, Pierce P, Milliron KJ, Liu G, Merajver SD. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not. Oncology Nursing Forum. 38: 572-81. PMID 21875844 DOI: 10.1188/11.Onf.572-581  0.419
2011 Rosenthal DT, Iyer H, Escudero S, Bao L, Wu Z, Ventura AC, Kleer CG, Arruda EM, Garikipati K, Merajver SD. p38γ promotes breast cancer cell motility and metastasis through regulation of RhoC GTPase, cytoskeletal architecture, and a novel leading edge behavior. Cancer Research. 71: 6338-49. PMID 21862636 DOI: 10.1158/0008-5472.Can-11-1291  0.826
2011 Spencer B, Banerjee M, Omar S, Khaled H, Anwar N, Zaghloul MS, Eissa S, Kleer CG, Dey S, Merajver SD, Soliman AS. Survival of inflammatory breast cancer patients compared to non-inflammatory breast cancer patients in Egypt. The Breast Journal. 17: 545-7. PMID 21827567 DOI: 10.1111/J.1524-4741.2011.01146.X  0.491
2011 Gilbert SF, Soliman AS, Iniesta M, Eissa M, Hablas A, Seifeldin IA, Strahley A, Banerjee M, Merajver SD. Androgen receptor polyglutamine tract length in Egyptian male breast cancer patients. Breast Cancer Research and Treatment. 129: 575-81. PMID 21505847 DOI: 10.1007/S10549-011-1510-6  0.464
2011 Gonzalez ME, DuPrie ML, Krueger H, Merajver SD, Ventura AC, Toy KA, Kleer CG. Histone methyltransferase EZH2 induces Akt-dependent genomic instability and BRCA1 inhibition in breast cancer. Cancer Research. 71: 2360-70. PMID 21406404 DOI: 10.1158/0008-5472.Can-10-1933  0.525
2011 Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz TA, Dirix LY, Levine PH, Lucci A, Krishnamurthy S, Robertson FM, Woodward WA, Yang WT, Ueno NT, Cristofanilli M. International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 22: 515-23. PMID 20603440 DOI: 10.1093/Annonc/Mdq345  0.548
2011 Katapodi MC, DeFlon SL, Milliron KJ, Northouse LL, Merajver S. Knowledge of risk factors and modes of gene transmission among women at risk for hereditary breast and ovarian cancer syndrome. Journal of Clinical Oncology. 29: e12017-e12017. DOI: 10.1200/Jco.2011.29.15_Suppl.E12017  0.531
2011 Wynn ML, Ventura AC, Garcia H, Sepulchre J, Merajver SD. Abstract 4907: Elucidating the role of retroactive signaling and kinase inhibitors on off-target drug effects Cancer Research. 71: 4907-4907. DOI: 10.1158/1538-7445.Am2011-4907  0.333
2011 Zhu L, Rosenthal DT, Jie Z, Bao L, Merajver S. Abstract 3842: RhoC is an essential determinant of breast cancer stem cell abundance and metastatic potential Cancer Research. 71: 3842-3842. DOI: 10.1158/1538-7445.Am2011-3842  0.81
2011 Rosenthal DT, Iyer H, Escudero S, Bao L, Wu Z, Ventura AC, Arruda EM, Garikipati K, Merajver SD. Abstract 1485: Identification of p38γ as a metastatic oncogene: Mechanism of action and clinical implications Cancer Research. 71: 1485-1485. DOI: 10.1158/1538-7445.Am2011-1485  0.713
2011 Kennedy EJ, Bracken EA, Wassenhove LDV, Bao L, Wu Z, Merajver SD. Abstract 1397: The effects of mevalonate pathway inhibitors on the motility and invasion of aggressive breast cancers Cancer Research. 71: 1397-1397. DOI: 10.1158/1538-7445.Am2011-1397  0.54
2010 Burson AM, Soliman AS, Ngoma TA, Mwaiselage J, Ogweyo P, Eissa MS, Dey S, Merajver SD. Clinical and epidemiologic profile of breast cancer in Tanzania. Breast Disease. 31: 33-41. PMID 21109721 DOI: 10.3233/Bd-2009-0296  0.567
2010 Rosenthal DT, Iyer H, Escudero S, Ventura AC, Arruda EM, Garikipati K, Merajver SD. From in vitro to in silico and back again: using biological and mathematical synergy to decipher breast cancer cell motility. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 2010: 3261-4. PMID 21096609 DOI: 10.1109/IEMBS.2010.5627224  0.801
2010 Bevers TB, Armstrong DK, Arun B, Carlson RW, Cowan KH, Daly MB, Fleming I, Garber JE, Gemignani M, Gradishar WJ, Krontiras H, Kulkarni S, Laronga C, Loftus L, Macdonald DJ, ... ... Merajver SD, et al. Breast cancer risk reduction. Journal of the National Comprehensive Cancer Network : Jnccn. 8: 1112-46. PMID 20971838 DOI: 10.6004/Jnccn.2010.0083  0.53
2010 Iniesta MD, Gorin MA, Chien LC, Thomas SM, Milliron KJ, Douglas JA, Merajver SD. Absence of CHEK2*1100delC mutation in families with hereditary breast cancer in North America. Cancer Genetics and Cytogenetics. 202: 136-40. PMID 20875877 DOI: 10.1016/J.Cancergencyto.2010.07.124  0.522
2010 Kumar P, Yadav A, Patel SN, Islam M, Pan Q, Merajver SD, Teknos TN. Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis. Molecular Cancer. 9: 206. PMID 20682068 DOI: 10.1186/1476-4598-9-206  0.353
2010 Wu M, Wu ZF, Rosenthal DT, Rhee EM, Merajver SD. Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers. Cancer. 116: 2768-82. PMID 20503409 DOI: 10.1002/Cncr.25181  0.812
2010 Dey S, Soliman AS, Hablas A, Seifeldein IA, Ismail K, Ramadan M, El-Hamzawy H, Wilson ML, Banerjee M, Boffetta P, Harford J, Merajver SD. Urban-rural differences in breast cancer incidence in Egypt (1999-2006). Breast (Edinburgh, Scotland). 19: 417-23. PMID 20452771 DOI: 10.1016/J.Breast.2010.04.005  0.528
2010 Pierce LJ, Phillips KA, Griffith KA, Buys S, Gaffney DK, Moran MS, Haffty BG, Ben-David M, Kaufman B, Garber JE, Merajver SD, Balmaña J, Meirovitz A, Domchek SM. Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy. Breast Cancer Research and Treatment. 121: 389-98. PMID 20411323 DOI: 10.1007/S10549-010-0894-Z  0.532
2010 Mooney C, Merajver S. Breast cancer screening recommendations: Dynamic extrapolation of limited data Breast Cancer Research and Treatment. 121: 143-146. PMID 20063195 DOI: 10.1007/S10549-009-0707-4  0.465
2010 Iniesta MD, Chien J, Wicha M, Merajver SD. One-hit effects and cancer. Cancer Prevention Research (Philadelphia, Pa.). 3: 12-5. PMID 20051368 DOI: 10.1158/1940-6207.Capr-09-0249  0.308
2010 Dey S, Hablas A, Seifeldin IA, Ismail K, Ramadan M, El-Hamzawy H, Wilson ML, Banerjee M, Boffetta P, Harford J, Merajver SD, Soliman AS. Urban-rural differences of gynaecological malignancies in Egypt (1999-2002). Bjog : An International Journal of Obstetrics and Gynaecology. 117: 348-55. PMID 20015310 DOI: 10.1111/J.1471-0528.2009.02447.X  0.516
2010 Dey S, Soliman AS, Hablas A, Seifeldin IA, Ismail K, Ramadan M, El-Hamzawy H, Wilson ML, Banerjee M, Boffetta P, Harford J, Merajver SD. Urban-rural differences in breast cancer incidence by hormone receptor status across 6 years in Egypt. Breast Cancer Research and Treatment. 120: 149-60. PMID 19548084 DOI: 10.1007/S10549-009-0427-9  0.475
2010 Rosenthal DT, Escudero S, Bao L, Wu Z, Ventura AC, Merajver SD. Abstract 5193: p38 gamma is a novel driver of breast cancer metastasis by modulating cellular motility Cancer Research. 70: 5193-5193. DOI: 10.1158/1538-7445.Am10-5193  0.816
2010 Wassenhove LDV, Jaffe ER, Wynn ML, Merajver SD. Abstract 37: Alterations in the metabolism of highly motile cells: Implications for cancer metastasis Cancer Research. 70: 37-37. DOI: 10.1158/1538-7445.Am10-37  0.44
2010 Kennedy EJ, Ventura AC, Wu Z, Garcia H, Maddur S, Merajver SD. Abstract 3174: Visualization of the activation/deactivation cycle of RhoC in inflammatory breast cancer Cancer Research. 70: 3174-3174. DOI: 10.1158/1538-7445.Am10-3174  0.374
2010 Wynn M, Ventura A, Garcia H, Merajver S. Abstract 2012: Off-target drug effects due to retroactivity in signaling pathways Cancer Research. 70: 2012-2012. DOI: 10.1158/1538-7445.Am10-2012  0.378
2010 Quinlan-Davidson M, Strahley A, Eissa M, Benider A, Benjaafar N, Hablas A, Karkouri M, Ramadan M, Eldein IS, Nayera A, Toy K, Merajver SD, Soliman AS. Abstract 1813: Frequency and risk factors of male breast cancer in Egypt and Morocco Cancer Research. 70: 1813-1813. DOI: 10.1158/1538-7445.Am10-1813  0.563
2010 Dey S, Soliman AS, Zhang Z, Hablas A, Seifeldin IA, Ramadan M, El-Hamzawy H, Harford J, Merajver SD. Abstract 1812: Urban-rural distribution of cancer profiles in Gharbiah, Egypt Cancer Research. 70: 1812-1812. DOI: 10.1158/1538-7445.Am10-1812  0.405
2010 Bosch-Barrera J, Merajver SD. Bisphosphonates in breast cancer: From metastasis to prevention Current Breast Cancer Reports. 2: 222-230. DOI: 10.1007/S12609-010-0025-1  0.51
2010 Rosenthal DT, Brenner JC, Merajver SD. Rho proteins in cancer The Rho Gtpases in Cancer. 29-42. DOI: 10.1007/978-1-4419-1111-7_2  0.745
2009 Gorin MA, Iniesta MD, Douglas JA, Milliron KJ, Merajver SD. Absence of the CHEK2*1100delC mutation in non-BRCA1/2 families with multiple cancer types in a high-risk clinic population of Caucasian ancestry. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 11040. PMID 27963982 DOI: 10.1200/Jco.2009.27.15_Suppl.11040  0.502
2009 Urba S, Schneider BJ, Hayman JA, Orringer M, Chang A, Pickens A, Pan C, Lee J, Foster J, Merajver S. Preoperative chemoradiation and postoperative adjuvant tetrathiomolybdate for patients with resectable esophageal cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e15504. PMID 27962224 DOI: 10.1200/Jco.2009.27.15_Suppl.E15504  0.309
2009 Soliman A, Allen K, Lo AC, Banerjee M, Hablas A, Benider A, Benchekroun N, Samir S, Omar HG, Merajver S, Mullan P. Differences in Reliability of Reproductive History Recall Among Women in North Africa. The International Electronic Journal of Health Education. 12: 150-161. PMID 25620888  0.322
2009 Iniesta MD, Mooney CJ, Merajver SD. Inflammatory breast cancer: what are the treatment options? Expert Opinion On Pharmacotherapy. 10: 2987-97. PMID 19954272 DOI: 10.1517/14656560903401638  0.498
2009 Pan Q, Rosenthal DT, Bao L, Kleer CG, Merajver SD. Antiangiogenic tetrathiomolybdate protects against Her2/neu-induced breast carcinoma by hypoplastic remodeling of the mammary gland. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 7441-6. PMID 19934283 DOI: 10.1158/1078-0432.Ccr-09-1361  0.758
2009 Islam M, Lin G, Brenner JC, Pan Q, Merajver SD, Hou Y, Kumar P, Teknos TN. RhoC expression and head and neck cancer metastasis. Molecular Cancer Research : McR. 7: 1771-80. PMID 19861405 DOI: 10.1158/1541-7786.Mcr-08-0512  0.423
2009 Khan GN, Gorin MA, Rosenthal D, Pan Q, Bao LW, Wu ZF, Newman RA, Pawlus AD, Yang P, Lansky EP, Merajver SD. Pomegranate fruit extract impairs invasion and motility in human breast cancer. Integrative Cancer Therapies. 8: 242-53. PMID 19815594 DOI: 10.1177/1534735409341405  0.772
2009 Li X, Gonzalez ME, Toy K, Filzen T, Merajver SD, Kleer CG. Targeted overexpression of EZH2 in the mammary gland disrupts ductal morphogenesis and causes epithelial hyperplasia. The American Journal of Pathology. 175: 1246-54. PMID 19661437 DOI: 10.2353/Ajpath.2009.090042  0.45
2009 Soliman AS, Banerjee M, Lo AC, Ismail K, Hablas A, Seifeldin IA, Ramadan M, Omar HG, Fokuda A, Harford JB, Merajver SD. High proportion of inflammatory breast cancer in the Population-based Cancer Registry of Gharbiah, Egypt. The Breast Journal. 15: 432-4. PMID 19601951 DOI: 10.1111/J.1524-4741.2009.00755.X  0.466
2009 Bao L, Gorin MA, Zhang M, Ventura AC, Pomerantz WC, Merajver SD, Teknos TN, Mapp AK, Pan Q. Preclinical development of a bifunctional cancer cell homing, PKCepsilon inhibitory peptide for the treatment of head and neck cancer. Cancer Research. 69: 5829-34. PMID 19567682 DOI: 10.1158/0008-5472.Can-08-3465  0.383
2009 Sparano JA, Moulder S, Kazi A, Coppola D, Negassa A, Vahdat L, Li T, Pellegrino C, Fineberg S, Munster P, Malafa M, Lee D, Hoschander S, Hopkins U, Hershman D, ... ... Merajver S, et al. Phase II trial of tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB-IIIC breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 2942-8. PMID 19351752 DOI: 10.1158/1078-0432.Ccr-08-2658  0.536
2009 Khan G, Merajver S. Copper chelation in cancer therapy using tetrathiomolybdate: An evolving paradigm Expert Opinion On Investigational Drugs. 18: 541-548. PMID 19335282 DOI: 10.1517/13543780902845622  0.372
2009 Lo AC, Georgopoulos A, Kleer CG, Banerjee M, Omar S, Khaled H, Eissa S, Hablas A, Omar HG, Douglas JA, Merajver SD, Soliman AS. Analysis of RhoC expression and lymphovascular emboli in inflammatory vs non-inflammatory breast cancers in Egyptian patients. Breast (Edinburgh, Scotland). 18: 55-9. PMID 19157876 DOI: 10.1016/J.Breast.2008.11.002  0.395
2009 Dey S, Soliman AS, Merajver SD. Xenoestrogens may be the cause of high and increasing rates of hormone receptor positive breast cancer in the world. Medical Hypotheses. 72: 652-6. PMID 19155145 DOI: 10.1016/J.Mehy.2008.10.025  0.562
2009 Ventura AC, Jackson TL, Merajver SD. On the role of cell signaling models in cancer research. Cancer Research. 69: 400-2. PMID 19147549 DOI: 10.1158/0008-5472.Can-08-4422  0.377
2009 Gonzalez ME, Li X, Toy K, DuPrie M, Ventura AC, Banerjee M, Ljungman M, Merajver SD, Kleer CG. Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1 Oncogene. 28: 843-853. PMID 19079346 DOI: 10.1038/Onc.2008.433  0.556
2009 Hensley Alford S, Schwartz K, Soliman A, Johnson CC, Gruber SB, Merajver SD. Breast cancer characteristics at diagnosis and survival among Arab-American women compared to European- and African-American women. Breast Cancer Research and Treatment. 114: 339-46. PMID 18415013 DOI: 10.1007/S10549-008-9999-Z  0.472
2009 Wasielewski M, Hanifi-Moghaddam P, Hollestelle A, Merajver SD, van den Ouweland A, Klijn JG, Ethier SP, Schutte M. Deleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell lines. Breast Cancer Research and Treatment. 113: 285-91. PMID 18297428 DOI: 10.1007/S10549-008-9942-3  0.401
2009 Rosenthal D, Dambro C, Brenner J, Wu Z, Merajver S. p38 MAPK is altered transcriptionally, translationally, and post-translationally in inflammatory breast cancer – significance and implications. Cancer Research. 69: 4061. DOI: 10.1158/0008-5472.Sabcs-4061  0.829
2009 Kumar P, Patel S, Islam M, Pan Q, Merajver S, Teknos T. P2.98. Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell invasion and promoting tumor cell anoikis Oral Oncology Supplement. 3: 192-193. DOI: 10.1016/J.Oos.2009.06.501  0.407
2009 Bao L, Gorin M, Merajver S, Teknos T, Pan Q. O114. Pre-clinical development of a bi-functional, cancer cell homing, PKCe inhibitory peptide for the treatment of head and neck cancer Oral Oncology Supplement. 3: 94. DOI: 10.1016/J.Oos.2009.06.199  0.411
2008 Worden FP, Teknos T, Lee J, Urba SG, Bradford CR, Carey T, Chepeha D, Wolf GT, Prince M, Mukherji S, Merajver SD. A phase II trial of tetrathiomolybdate (TM) in metastatic head & neck cancer (MHNC) patients (pts) after treatment with platinum & 5-fluorouracil (P&5FU). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 6080. PMID 27947824 DOI: 10.1200/Jco.2008.26.15_Suppl.6080  0.301
2008 Houchens NW, Merajver SD. Molecular determinants of the inflammatory breast cancer phenotype. Oncology (Williston Park, N.Y.). 22: 1556-61; discussion . PMID 19198217  0.434
2008 Huang W, Zhang Y, Varambally S, Chinnaiyan AM, Banerjee M, Merajver SD, Kleer CG. Inhibition of CCN6 (Wnt-1-induced signaling protein 3) down-regulates E-cadherin in the breast epithelium through induction of snail and ZEB1. The American Journal of Pathology. 172: 893-904. PMID 18321996 DOI: 10.2353/Ajpath.2008.070899  0.438
2008 Liu S, Ginestier C, Charafe-Jauffret E, Foco H, Kleer CG, Merajver SD, Dontu G, Wicha MS. BRCA1 regulates human mammary stem/progenitor cell fate. Proceedings of the National Academy of Sciences of the United States of America. 105: 1680-5. PMID 18230721 DOI: 10.1073/Pnas.0711613105  0.477
2008 Lo AC, Kleer CG, Banerjee M, Omar S, Khaled H, Eissa S, Hablas A, Douglas JA, Alford SH, Merajver SD, Soliman AS. Molecular epidemiologic features of inflammatory breast cancer: a comparison between Egyptian and US patients. Breast Cancer Research and Treatment. 112: 141-7. PMID 18058225 DOI: 10.1007/S10549-007-9833-Z  0.403
2008 Ventura AC, Merajver SD. Genetic determinants of aggressive breast cancer. Annual Review of Medicine. 59: 199-212. PMID 17914925 DOI: 10.1146/Annurev.Med.59.060106.184830  0.552
2008 Pierce LJ, Griffith KA, Buys S, Gaffney D, Haffty B, Moran M, Ben-David M, Garber J, Merajver SD, Meirovitz A, Domchek S. Outcomes following breast conservation versus mastectomy in BRCA1/2 carriers with early-stage breast cancer Journal of Clinical Oncology. 26: 536-536. DOI: 10.1200/Jco.2008.26.15_Suppl.536  0.512
2007 Khan GN, Merajver SD. Modulation of angiogenesis for cancer prevention: strategies based on antioxidants and copper deficiency. Current Pharmaceutical Design. 13: 3584-90. PMID 18220795 DOI: 10.2174/138161207782794202  0.364
2007 Bevers TB, Armstrong DK, Arun B, Carlson RW, Cowan KH, Daly MB, Fleming I, Garber JE, Gemignani M, Gradishar WJ, Krontiras H, Kulkarni S, Laronga C, Lawton T, Loftus L, ... ... Merajver SD, et al. Breast cancer risk reduction. Journal of the National Comprehensive Cancer Network : Jnccn. 5: 676-701. PMID 17927926  0.439
2007 Evelyn CR, Wade SM, Wang Q, Wu M, Iñiguez-Lluhí JA, Merajver SD, Neubig RR. CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling. Molecular Cancer Therapeutics. 6: 2249-60. PMID 17699722 DOI: 10.1158/1535-7163.Mct-06-0782  0.419
2007 Wu M, Wu ZF, Merajver SD. Rho proteins and cell-matrix interactions in cancer. Cells, Tissues, Organs. 185: 100-3. PMID 17587814 DOI: 10.1159/000101309  0.39
2007 Kleer CG, Zhang Y, Merajver SD. CCN6 (WISP3) as a new regulator of the epithelial phenotype in breast cancer. Cells, Tissues, Organs. 185: 95-9. PMID 17587813 DOI: 10.1159/000101308  0.565
2007 Hassouneh B, Islam M, Nagel T, Pan Q, Merajver SD, Teknos TN. Tetrathiomolybdate promotes tumor necrosis and prevents distant metastases by suppressing angiogenesis in head and neck cancer. Molecular Cancer Therapeutics. 6: 1039-45. PMID 17363496 DOI: 10.1158/1535-7163.Mct-06-0524  0.349
2007 Merajver SD. Further perspectives on inflammatory breast cancer Oncology. 21: 686-687.  0.46
2006 Shah NM, Soliman AS, Benerjee M, Merajver SD, Ismail K, Seifeldin I, Hablas A, Zarzour A, Abdel-Aziz A, Ben Ayed F, Chamberlain RM. Knowledge gained after a brief CME module on breast cancer diagnosis. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. 21: 169-74. PMID 17371184 DOI: 10.1207/S15430154Jce2103_17  0.405
2006 Pan Q, Bao LW, Teknos TN, Merajver SD. Targeted disruption of protein kinase C epsilon reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma. Cancer Research. 66: 9379-84. PMID 17018591 DOI: 10.1158/0008-5472.Can-06-2646  0.331
2006 Pierce LJ, Levin AM, Rebbeck TR, Ben-David MA, Friedman E, Solin LJ, Harris EE, Gaffney DK, Haffty BG, Dawson LA, Narod SA, Olivotto IA, Eisen A, Whelan TJ, Olopade OI, ... ... Merajver SD, et al. Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 2437-43. PMID 16636335 DOI: 10.1200/Jco.2005.02.7888  0.505
2006 Ding L, Erdmann C, Chinnaiyan AM, Merajver SD, Kleer CG. Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissues. Cancer Research. 66: 4095-9. PMID 16618729 DOI: 10.1158/0008-5472.Can-05-4300  0.516
2006 Elstrodt F, Hollestelle A, Nagel JH, Gorin M, Wasielewski M, van den Ouweland A, Merajver SD, Ethier SP, Schutte M. BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants. Cancer Research. 66: 41-5. PMID 16397213 DOI: 10.1158/0008-5472.Can-05-2853  0.443
2006 Van den Eynden GG, Van Laere SJ, Van der Auwera I, Merajver SD, Van Marck EA, van Dam P, Vermeulen PB, Dirix LY, van Golen KL. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer. Breast Cancer Research and Treatment. 95: 219-28. PMID 16244790 DOI: 10.1007/S10549-005-9002-1  0.577
2005 Merajver SD, Usmani SZ. Multifaceted role of Rho proteins in angiogenesis. Journal of Mammary Gland Biology and Neoplasia. 10: 291-8. PMID 16900393 DOI: 10.1007/S10911-006-9002-8  0.312
2005 Wu M, Merajver SD. Molecular biology of inflammatory breast cancer: applications to diagnosis, prognosis, and therapy. Breast Disease. 22: 25-34. PMID 16735784 DOI: 10.3233/Bd-2006-22104  0.515
2005 Zhang Y, Pan Q, Zhong H, Merajver SD, Kleer CG. Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells. Breast Cancer Research : Bcr. 7: R1080-9. PMID 16457688 DOI: 10.1186/Bcr1351  0.4
2005 Zeidler M, Varambally S, Cao Q, Chinnaiyan AM, Ferguson DO, Merajver SD, Kleer CG. The polycomb group protein EZH2 impairs DNA repair in breast epithelial cells Neoplasia. 7: 1011-1019. PMID 16331887 DOI: 10.1593/Neo.05472  0.435
2005 Goodman VL, Brewer GJ, Merajver SD. Control of copper status for cancer therapy. Current Cancer Drug Targets. 5: 543-9. PMID 16305350 DOI: 10.2174/156800905774574066  0.346
2005 Kleer CG, Griffith KA, Sabel MS, Gallagher G, van Golen KL, Wu ZF, Merajver SD. RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast. Breast Cancer Research and Treatment. 93: 101-10. PMID 16187229 DOI: 10.1007/S10549-005-4170-6  0.577
2005 Pan Q, Bao LW, Kleer CG, Sabel MS, Griffith KA, Teknos TN, Merajver SD. Protein kinase Cε is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy Cancer Research. 65: 8366-8371. PMID 16166314 DOI: 10.1158/0008-5472.Can-05-0553  0.557
2005 Lin M, DiVito MM, Merajver SD, Boyanapalli M, van Golen KL. Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and caveolin-1. Molecular Cancer. 4: 21. PMID 15969750 DOI: 10.1186/1476-4598-4-21  0.442
2005 Wang C, Gonzalez R, Milliron KJ, Strecher VJ, Merajver SD. Genetic counseling for BRCA1/2: a randomized controlled trial of two strategies to facilitate the education and counseling process. American Journal of Medical Genetics. Part A. 134: 66-73. PMID 15690408 DOI: 10.1002/Ajmg.A.30577  0.32
2005 Merajver S, Harris A. Introduction on Angiogenesis in Breast Cancer Journal of Mammary Gland Biology and Neoplasia. 10: 281-282. DOI: 10.1007/S10911-006-9000-X  0.504
2004 Goodman VL, Brewer GJ, Merajver SD. Copper deficiency as an anti-cancer strategy. Endocrine-Related Cancer. 11: 255-63. PMID 15163301 DOI: 10.1677/Erc.0.0110255  0.357
2004 Kleer CG, Zhang Y, Pan Q, Merajver SD. WISP3 (CCN6) Is a Secreted Tumor-Suppressor Protein that Modulates IGF Signaling in Inflammatory Breast Cancer Neoplasia. 6: 179-185. PMID 15140407 DOI: 10.1593/Neo.03316  0.527
2004 Van den Eynden GG, Van der Auwera I, Van Laere S, Colpaert CG, van Dam P, Merajver S, Kleer CG, Harris AL, Van Marck EA, Dirix LY, Vermeulen PB. Validation of a tissue microarray to study differential protein expression in inflammatory and non-inflammatory breast cancer. Breast Cancer Research and Treatment. 85: 13-22. PMID 15039594 DOI: 10.1023/B:Brea.0000021028.33926.A8  0.536
2004 Wu M, Wu ZF, Kumar-Sinha C, Chinnaiyan A, Merajver SD. RhoC induces differential expression of genes involved in invasion and metastasis in MCF10A breast cells Breast Cancer Research and Treatment. 84: 3-12. PMID 14999149 DOI: 10.1023/B:Brea.0000018426.76893.21  0.528
2004 Kleer CG, Zhang Y, Pan Q, Gallagher G, Wu M, Wu ZF, Merajver SD. WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer. Breast Cancer Research : Bcr. 6: R110-5. PMID 14696649 DOI: 10.1186/Bcr755  0.54
2004 Merajver S. Why are Rho proteins important in cancer Breast Cancer Research and Treatment. 84. DOI: 10.1023/B:Brea.0000018441.44549.36  0.441
2003 Merajver SD, Milliron K. Breast cancer risk assessment: A guide for clinicians using the NCCN breast cancer risk reduction guidelines Jnccn Journal of the National Comprehensive Cancer Network. 1: 297-301. PMID 19768887 DOI: 10.6004/Jnccn.2003.0027  0.541
2002 van Golen KL, Bao L, DiVito MM, Wu Z, Prendergast GC, Merajver SD. Reversion of RhoC GTPase-induced inflammatory breast cancer phenotype by treatment with a farnesyl transferase inhibitor. Molecular Cancer Therapeutics. 1: 575-83. PMID 12479217  0.427
2002 Narod SA, Dubé MP, Klijn J, Lubinski J, Lynch HT, Ghadirian P, Provencher D, Heimdal K, Moller P, Robson M, Offit K, Isaacs C, Weber B, Friedman E, Gershoni-Baruch R, ... ... Merajver S, et al. Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Journal of the National Cancer Institute. 94: 1773-9. PMID 12464649 DOI: 10.1093/Jnci/94.23.1773  0.504
2002 van Golen KL, Bao L, Brewer GJ, Pienta KJ, Kamradt JM, Livant DL, Merajver SD. Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma. Neoplasia (New York, N.Y.). 4: 373-9. PMID 12192595 DOI: 10.1038/Sj.Neo.7900258  0.343
2002 Kleer CG, Tseng MD, Gutsch DE, Rochford RA, Wu Z, Joynt LK, Helvie MA, Chang T, Van Golen KL, Merajver SD. Detection of Epstein-Barr virus in rapidly growing fibroadenomas of the breast in immunosuppressed hosts. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 15: 759-64. PMID 12118114 DOI: 10.1038/Modpathol.3880602  0.469
2002 van Golen KL, Bao LW, Pan Q, Miller FR, Wu ZF, Merajver SD. Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer. Clinical & Experimental Metastasis. 19: 301-11. PMID 12090470 DOI: 10.1023/A:1015518114931  0.51
2002 Kleer CG, Zhang Y, Pan Q, van Golen KL, Wu ZF, Livant D, Merajver SD. WISP3 is a novel tumor suppressor gene of inflammatory breast cancer. Oncogene. 21: 3172-80. PMID 12082632 DOI: 10.1038/Sj.Onc.1205462  0.492
2002 Munshi HG, Merajver SD, Valdez R, Baker LH, Cooney KA. Metastatic dedifferentiated chordoma with elevated beta-hCG: a case report. American Journal of Clinical Oncology. 25: 274-6. PMID 12040287 DOI: 10.1097/00000421-200206000-00014  0.325
2002 Khan MK, Miller MW, Taylor J, Gill NK, Dick RD, Van Golen K, Brewer GJ, Merajver SD. Radiotherapy and antiangiogenic TM in lung cancer. Neoplasia (New York, N.Y.). 4: 164-70. PMID 11896571 DOI: 10.1038/Sj.Neo.7900218  0.341
2002 Kleer CG, van Golen KL, Zhang Y, Wu ZF, Rubin MA, Merajver SD. Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. The American Journal of Pathology. 160: 579-84. PMID 11839578 DOI: 10.1016/S0002-9440(10)64877-8  0.494
2002 Peterson EA, Milliron KJ, Lewis KE, Goold SD, Merajver SD. Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 11: 79-87. PMID 11815404  0.307
2001 Trask PC, Paterson AG, Wang C, Hayasaka S, Milliron KJ, Blumberg LR, Gonzalez R, Murray S, Merajver SD. Cancer-specific worry interference in women attending a breast and ovarian cancer risk evaluation program: Impact on emotional distress and health functioning Psycho-Oncology. 10: 349-360. PMID 11536413 DOI: 10.1002/Pon.510  0.521
2001 Kleer CG, Van Golen KL, Braun T, Merajver SD. Persistent E-cadherin expression in inflammatory breast cancer Modern Pathology. 14: 458-464. PMID 11353057 DOI: 10.1038/Modpathol.3880334  0.45
2001 Fisher B, Anderson S, Tan-Chiu E, Wolmark N, Wickerham DL, Fisher ER, Dimitrov NV, Atkins JN, Abramson N, Merajver S, Romond EH, Kardinal CG, Shibata HR, Margolese RG, Farrar WB. Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 19: 931-42. PMID 11181655 DOI: 10.1200/Jco.2001.19.4.931  0.444
2001 Merajver S, Wu Z, Chang T, Mirshahidi H, Meltzer P, vanGolen K. Microarray analysis of RhoC-transformed mammary epithelial cells suggests molecular mechanisms of inflammatory breast cancer Nature Genetics. 27: 73-73. DOI: 10.1038/87212  0.528
2000 Kleer CG, van Golen KL, Merajver SD. Molecular biology of breast cancer metastasis. Inflammatory breast cancer: Clinical syndrome and molecular determinants Breast Cancer Research. 2: 423-429. PMID 11250736 DOI: 10.1186/Bcr89  0.569
2000 Van Golen KL, Wu ZF, Qiao XT, Bao LW, Merajver SD. RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells Neoplasia. 2: 418-425. PMID 11191108 DOI: 10.1038/Sj.Neo.7900115  0.487
2000 Van Golen KL, Wu ZF, Xiao Tan Qiao, Li Wei Bao, Merajver SD. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype Cancer Research. 60: 5832-5838. PMID 11059780  0.478
1999 Van Golen KL, Davies S, Wu ZF, Wang Y, Bucana CD, Root H, Chandrasekharappa S, Strawderman M, Ethier SP, Merajver SD. A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype Clinical Cancer Research. 5: 2511-2519. PMID 10499627  0.492
1999 Van Golen K, Milliron K, Davies S, Merajver SD. BRCA-associated cancer risk: Molecular biology and clinical practice Journal of Laboratory and Clinical Medicine. 134: 11-18. PMID 10402055 DOI: 10.1016/S0022-2143(99)90049-5  0.394
1997 Merajver SD, Weber BL, Cody R, Zhang D, Strawderman M, Calzone KA, LeClaire V, Levin A, Irani J, Halvie M, August D, Wicha M, Lichter A, Pierce LJ. Breast conservation and prolonged chemotherapy for locally advanced breast cancer: The University of Michigan experience Journal of Clinical Oncology. 15: 2873-2881. PMID 9256131 DOI: 10.1200/Jco.1997.15.8.2873  0.395
1997 Helvie MA, Roubidoux MA, Weber BL, Merajver SD. Mammography of breast carcinoma in women who have mutations of the breast cancer gene BRCA1: Initial experience American Journal of Roentgenology. 168: 1599-1602. PMID 9168735 DOI: 10.2214/Ajr.168.6.9168735  0.548
1996 Merajver SD, Petty EM. Risk assessment and presymptomatic molecular diagnosis in hereditary breast cancer Clinics in Laboratory Medicine. 16: 139-167. PMID 8867588 DOI: 10.1016/S0272-2712(18)30292-0  0.556
1996 Couch FJ, Farid LM, DeShano ML, Tavtigian SV, Calzone K, Campeau L, Peng Y, Bogden B, Chen Q, Neuhausen S, Shattuck-Eidens D, Godwin AK, Daly M, Radford DM, Sedlacek S, ... ... Merajver S, et al. BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nature Genetics. 13: 123-5. PMID 8673091 DOI: 10.1038/Ng0596-123  0.518
1996 Pierce L, Adler D, Helvie M, Lichter A, Merajver S. The use of mammography in breast preservation in locally advanced breast cancer. International Journal of Radiation Oncology, Biology, Physics. 34: 571-7. PMID 8621280 DOI: 10.1016/0360-3016(95)02042-X  0.517
1996 Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Merajver S, Thorlacius S, Offit K, Stoppa-Lyonnet D, Belanger C, Bell R, Berry S, Bogden R, Chen Q, et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds Nature Genetics. 12: 333-337. PMID 8589730 DOI: 10.1038/Ng0396-333  0.4
1995 Merajver SD, Frank TS, Xu J, Pham TM, Calzone KA, Bennett-Baker P, Chamberlain J, Boyd J, Garber JE, Collins FS. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 1: 539-44. PMID 9816013  0.366
1995 Couch FJ, Garber J, Kiousis S, Calzone K, Hauser ER, Merajver SD, Frank TS, Boehnke M, Chamberlain JS, Collins FS. Genetic analysis of eight breast-ovarian cancer families with suspected BRCA1 mutations. Journal of the National Cancer Institute. Monographs. 9-14. PMID 8573462  0.343
1995 Hoskins KF, Stopfer JE, Calzone KA, Weber BL, Merajver SD, Rebbeck TR, Garber JE. Assessment and Counseling for Women With a Family History of Breast Cancer: A Guide for Clinicians Jama: the Journal of the American Medical Association. 273: 577-585. PMID 7837392 DOI: 10.1001/Jama.1995.03520310075033  0.487
1995 Merajver SD, Pham TM, Caduff RF, Chen M, Poy EL, Cooney KA, Weber BL, Collins FS, Johnston C, Frank TS. Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nature Genetics. 9: 439-43. PMID 7795652 DOI: 10.1038/Ng0495-439  0.389
1995 Weber BL, Abel KJ, Couch FJ, Merajver S, Castilla L, Brody LC, Collins FS. Transcript identification in the BRCA1 candidate region Breast Cancer Research and Treatment. 33: 115-124. PMID 7749139 DOI: 10.1007/Bf00682719  0.468
1994 Weber BL, Abel KJ, Brody LC, Flejter WL, Chandrasekharappa SC, Couch FJ, Merajver SD, Collins FS. Familial breast cancer: Approaching the isolation of a susceptibility gene Cancer. 74: 1013-1020. PMID 8039134 DOI: 10.1002/1097-0142(19940801)74:3+<1013::Aid-Cncr2820741507>3.0.Co;2-#  0.527
1994 Weber BL, Abel KJ, Couch FJ, Merajver SD, Chandrasekharappa SC, Castilla L, McKinley D, Ho PP, Calzone K, Frank TS. Progress toward isolation of a breast cancer susceptibility gene, BRCA1. Cold Spring Harbor Symposia On Quantitative Biology. 59: 531-6. PMID 7587109 DOI: 10.1101/Sqb.1994.059.01.059  0.432
Show low-probability matches.